Naturally-Occurring Polymorphisms in QcrB Are Responsible for Resistance to Telacebec in Mycobacterium abscessus
Authors:
- 10 October 2019
- journal article
- letter
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 5 (12) , 2055-2060
Abstract
Mycobacterium abscessus is a rapidly growing non-tuberculous mycobacteria that is quickly emerging as a global health concern. M. abscessus pulmonary infections are frequently intractable due to the high intrinsic resistance to most antibiotics. Therefore, there is an urgent need to discover effective pharmacological options for M. abscessus infections. In this study, the potency of the anti-tuberculosis drug Telacebec (Q203) was evaluated against M. abscessus. Q203 is a clinical-stage drug candidate targeting the sub-unit QcrB of the cytochrome bc1:aa3 terminal oxidase. We demonstrated that the presence of four naturally-occurring polymorphisms in the M. abscessus QcrB are responsible for the high resistance of the bacterium to Q203. Genetics reversion of the four polymorphism sensitized M. abscessus to Q203. While this study highlights the limitation of a direct drug repurposing approach of Q203 and related drugs for M. abscessus infections, it reveals that the M. abscessus cytochrome bc1:aa3 respiratory branch is sensitive to chemical inhibition.Keywords
Funding Information
- Nanyang Technological University
- Institute for Health Technologies, Nanyang Technological University
- Lee Kong Chian School of Medicine, Nanyang Technological University
This publication has 31 references indexed in Scilit:
- Clinical and microbiological characteristics of non-tuberculous mycobacteria diseases in Singapore with a focus on pulmonary disease, 2012-2016BMC Infectious Diseases, 2019
- Profiling non-tuberculous mycobacteria in an Asian setting: characteristics and clinical outcomes of hospitalized patients in SingaporeBMC Pulmonary Medicine, 2018
- A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013Annals of the American Thoracic Society, 2017
- US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosisThorax, 2015
- Rapidly growing mycobacteria in Singapore, 2006–2011Clinical Microbiology and Infection, 2015
- Mycobacterium abscessus: a new antibiotic nightmareJournal of Antimicrobial Chemotherapy, 2012
- Nontuberculous Mycobacterial Lung Disease Prevalence at Four Integrated Health Care Delivery SystemsAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Cohort Study of Molecular Identification and Typing of Mycobacterium abscessus, Mycobacterium massiliense , and Mycobacterium bolletiiJournal of Clinical Microbiology, 2009
- An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Infections Due to Rapidly Growing MycobacteriaClinical Infectious Diseases, 2006